Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dry Eye Syndromes | 12 | 2022 | 387 | 3.290 |
Why?
|
Th17 Cells | 9 | 2021 | 793 | 2.190 |
Why?
|
Uveitis | 2 | 2023 | 396 | 1.190 |
Why?
|
Autoimmunity | 5 | 2021 | 1350 | 1.160 |
Why?
|
Autoimmune Diseases | 5 | 2023 | 2238 | 1.120 |
Why?
|
Corneal Transplantation | 4 | 2022 | 321 | 0.900 |
Why?
|
Interleukin-23 | 2 | 2020 | 201 | 0.750 |
Why?
|
Cornea | 7 | 2022 | 1332 | 0.710 |
Why?
|
Interleukin-7 | 2 | 2016 | 143 | 0.630 |
Why?
|
Immunologic Memory | 3 | 2020 | 1355 | 0.580 |
Why?
|
T-Lymphocyte Subsets | 3 | 2016 | 1798 | 0.560 |
Why?
|
Retinal Diseases | 1 | 2023 | 704 | 0.550 |
Why?
|
Interferon-gamma | 3 | 2017 | 3145 | 0.540 |
Why?
|
Retinal Degeneration | 1 | 2020 | 413 | 0.530 |
Why?
|
Interleukin-15 | 1 | 2016 | 185 | 0.520 |
Why?
|
Interleukin-2 | 2 | 2020 | 1887 | 0.510 |
Why?
|
Immunity | 1 | 2020 | 994 | 0.470 |
Why?
|
Scopolamine | 2 | 2013 | 93 | 0.450 |
Why?
|
Disease Models, Animal | 11 | 2023 | 18221 | 0.410 |
Why?
|
Muscarinic Antagonists | 1 | 2013 | 135 | 0.410 |
Why?
|
Adoptive Transfer | 4 | 2019 | 818 | 0.370 |
Why?
|
Inflammation | 4 | 2023 | 10760 | 0.310 |
Why?
|
Conjunctiva | 3 | 2022 | 479 | 0.250 |
Why?
|
Stress, Physiological | 1 | 2013 | 1403 | 0.250 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2019 | 3077 | 0.210 |
Why?
|
Graft Survival | 4 | 2019 | 3820 | 0.210 |
Why?
|
Th1 Cells | 3 | 2019 | 1027 | 0.200 |
Why?
|
Mice | 14 | 2023 | 81368 | 0.200 |
Why?
|
Lacrimal Apparatus | 2 | 2014 | 223 | 0.200 |
Why?
|
Killer Cells, Natural | 1 | 2011 | 2191 | 0.190 |
Why?
|
Mice, Inbred C57BL | 10 | 2020 | 22115 | 0.160 |
Why?
|
Flow Cytometry | 7 | 2014 | 5863 | 0.160 |
Why?
|
Animals | 16 | 2023 | 168201 | 0.150 |
Why?
|
Virulence | 1 | 2021 | 1299 | 0.150 |
Why?
|
Receptors, Interleukin-15 | 1 | 2016 | 13 | 0.140 |
Why?
|
Receptors, Interleukin-7 | 1 | 2016 | 40 | 0.140 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4366 | 0.140 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3800 | 0.140 |
Why?
|
STAT5 Transcription Factor | 1 | 2016 | 265 | 0.130 |
Why?
|
Keratoconjunctivitis Sicca | 1 | 2014 | 26 | 0.120 |
Why?
|
Interleukin-12 | 1 | 2017 | 577 | 0.120 |
Why?
|
Receptors, CCR7 | 1 | 2014 | 107 | 0.120 |
Why?
|
Aqueous Humor | 1 | 2014 | 153 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2014 | 119 | 0.110 |
Why?
|
Keratoplasty, Penetrating | 1 | 2014 | 144 | 0.110 |
Why?
|
Chemokine CCL20 | 1 | 2013 | 64 | 0.110 |
Why?
|
Green Fluorescent Proteins | 1 | 2019 | 2063 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1788 | 0.110 |
Why?
|
Eye | 2 | 2017 | 712 | 0.110 |
Why?
|
Receptors, CCR6 | 1 | 2013 | 74 | 0.110 |
Why?
|
Tears | 1 | 2014 | 251 | 0.110 |
Why?
|
Receptors, Muscarinic | 1 | 2013 | 157 | 0.100 |
Why?
|
Corneal Neovascularization | 1 | 2014 | 185 | 0.100 |
Why?
|
Epithelium | 1 | 2017 | 1603 | 0.100 |
Why?
|
Antigen-Presenting Cells | 2 | 2019 | 963 | 0.100 |
Why?
|
Apoptosis | 2 | 2020 | 9476 | 0.100 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2012 | 34 | 0.100 |
Why?
|
Chronic Disease | 2 | 2020 | 9311 | 0.100 |
Why?
|
Interleukin-17 | 1 | 2017 | 911 | 0.090 |
Why?
|
Lymphocyte Activation | 2 | 2019 | 5463 | 0.080 |
Why?
|
Lymph Nodes | 3 | 2019 | 3461 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2016 | 2456 | 0.070 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1703 | 0.070 |
Why?
|
Th2 Cells | 1 | 2013 | 1056 | 0.070 |
Why?
|
Docosahexaenoic Acids | 1 | 2014 | 907 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 2 | 2014 | 1810 | 0.070 |
Why?
|
Mice, Inbred BALB C | 4 | 2019 | 6188 | 0.070 |
Why?
|
Signal Transduction | 2 | 2020 | 23416 | 0.060 |
Why?
|
Cytokines | 3 | 2019 | 7373 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2019 | 661 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4570 | 0.060 |
Why?
|
Blotting, Western | 1 | 2011 | 5034 | 0.050 |
Why?
|
Dendritic Cells | 1 | 2014 | 2722 | 0.050 |
Why?
|
RNA | 1 | 2012 | 2713 | 0.050 |
Why?
|
Cell Movement | 1 | 2013 | 5200 | 0.050 |
Why?
|
Graft Rejection | 1 | 2014 | 4446 | 0.050 |
Why?
|
Homeostasis | 1 | 2012 | 3321 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2016 | 10432 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 3045 | 0.040 |
Why?
|
RNA, Messenger | 2 | 2014 | 12758 | 0.040 |
Why?
|
Humans | 7 | 2023 | 760617 | 0.040 |
Why?
|
Female | 8 | 2016 | 392148 | 0.040 |
Why?
|
Transplantation, Homologous | 2 | 2014 | 4804 | 0.030 |
Why?
|
Fluorophotometry | 1 | 2014 | 40 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 2016 | 913 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 306 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2014 | 63 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11874 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2014 | 127 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2014 | 508 | 0.030 |
Why?
|
Corneal Stroma | 1 | 2014 | 171 | 0.030 |
Why?
|
Lymphangiogenesis | 1 | 2014 | 171 | 0.030 |
Why?
|
Isoantigens | 1 | 2014 | 551 | 0.020 |
Why?
|
Efferent Pathways | 1 | 2012 | 165 | 0.020 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2012 | 140 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2014 | 632 | 0.020 |
Why?
|
Kinetics | 1 | 2019 | 6370 | 0.020 |
Why?
|
Afferent Pathways | 1 | 2012 | 298 | 0.020 |
Why?
|
Ophthalmic Solutions | 1 | 2012 | 312 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2014 | 1336 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11069 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2016 | 18937 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2014 | 974 | 0.020 |
Why?
|
Interleukin-1beta | 1 | 2014 | 998 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1034 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1614 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4845 | 0.020 |
Why?
|
Chemokines | 1 | 2012 | 954 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 1349 | 0.020 |
Why?
|
Nitriles | 1 | 2012 | 971 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2014 | 2409 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2200 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9529 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2012 | 1970 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2014 | 10175 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2017 | 4174 | 0.010 |
Why?
|
Antibodies, Neutralizing | 1 | 2013 | 1936 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4341 | 0.010 |
Why?
|
Male | 4 | 2019 | 360358 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2014 | 11514 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13495 | 0.010 |
Why?
|
Time Factors | 1 | 2016 | 39913 | 0.010 |
Why?
|
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_